The Effectiveness of a One-stop Electronic Clinic for Psychological Service (eClinic) in Hong Kong
2026년 5월 14일 업데이트: New Life Psychiatric Rehabilitation Association
With an increasing need for effective and accessible mental health services, telepsychology can be one promising solution to narrowing the gap between demand and supply.
Our one-stop electronic clinic of psychological service (eClinic) aims to deliver evidence-based treatments to individuals with moderate to severe emotional disorders of various kinds in Hong Kong.
This study examines the cost-effectiveness and cost-efficiency of a hybrid model of telepsychology, in which contact with therapists focuses on facilitating service users' self-learning based on our online interactive modules.
Results will shed light on the benefits of telepsychology to promoting access to mental health services in Hong Kong.
연구 개요
연구 유형
관찰
등록 (실제)
420
연락처 및 위치
이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.
연구 장소
-
-
Hong Kong
-
Hong Kong, Hong Kong, 홍콩
- New Life Psychiatric Rehabilitation Association
-
-
참여기준
연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
건강한 자원 봉사자를 받아들입니다
아니
샘플링 방법
비확률 샘플
연구 인구
Individuals aged between 15 and 35 years that are able to speak, read, and write Chinese, and present with moderate to severe depression or anxiety at the time of intake.
설명
Inclusion Criteria:
- Screened eligible for and enrolled in the eClinic service
- Age between 15 and 35 years
- Speak, read, and write Chinese
- Present with moderate to severe depression (i.e., Patient Health Questionnaire-9 (PHQ-9) total score ≥ 10) or anxiety (i.e., Generalized Anxiety Disorder-7 (GAD-7) total score ≥ 8)
Exclusion Criteria:
- Present with a history of psychosis in the recent 2 years
- Present with severe risk for self-harm/suicide (i.e., indicated as being at higher risk on the P4 suicidality screener during the service-related screening procedure prior to enrollment in the eClinic service)
- Present with active homicidal ideations (i.e., assessed during the service-related screening procedure prior to enrollment in the eClinic service)
- Demonstrate sub-average intelligence (e.g., based on a history of intellectual disability)
- Concurrently receive other psychological services
공부 계획
이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.
연구는 어떻게 설계됩니까?
디자인 세부사항
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Patient Health Questionnaire-9 (PHQ-9)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The PHQ-9 measures the presence of depressive symptoms in the recent two weeks.
The scale measures the nine diagnostic criteria of major depressive disorder on a scale from 0 = not at all to 3 = nearly every day, according to Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV).
Total score on the PHQ-9 ranges from 0 to 27, with higher scores indicating higher distress.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Generalized Anxiety Disorder-7 (GAD-7)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The GAD-7 assesses Generalized Anxiety Disorder (GAD) symptoms in the recent two weeks.
It consists of 7 items, each rated on a 4-point Likert scale from 0 = not at all to 3 = nearly every day.
Total score on the GAD-7 ranges from 0 to 21.
A higher GAD-7 score indicates more severe impairment related to GAD symptoms.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Brief Experiential Avoidance Questionnaire (BEAQ)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The 15-item BEAQ assesses several domains of experiential avoidance.
Items are rated on a 6-point Likert scale of 1 = strong disagree to 6 = strong agree.
Total score of the BEAQ ranges from 15 to 90, with a higher score representing greater experiential avoidance.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Difficulties in Emotion Regulation Scale-16 (DERS-16)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The DERS-16 assesses level of difficulties with emotion regulation.
Each of the 16 items is rated on a 5-point Likert scale of 1 = almost never to 5 = almost always, with a total score ranges from 16 to 80.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Cognitive Distortions Questionnaire (CD-Quest)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The CD-Quest is a self-report measure that contains 15 bi-dimensional items that measure the frequency and intensity of 15 cognitive distortions.
For each type of cognitive distortions, participants indicate if it has occurred or not; for any occurrence, individuals rate the frequency and intensity of the cognitive distortion on a 3x3 grid.
Therefore, score on each item ranges from 0 = no (it did not occur) to 5 = occurs almost all the time and with an intensity of more than 70%.
Total score of the CD-Quest ranges from 0 to 75, with a higher score representing a higher frequency and intensity of cognitive distortions.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Cognitive Flexibility Inventory (CFI)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The CFI is a self-report measure of cognitive flexibility.
20 items of the CFI are rated on a 7-point Likert scale of 1 (strongly disagree) to 7 (strongly agree).
Total score of the CFI ranges from 20 to 140, with higher scores indicating greater cognitive flexibility.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Gratitude Questionnaire-5 (GQ-5)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The GQ-5 is a self-reported instrument that assesses gratitude.
Five items of the GQ-5 are rated on a 7-point Likert scale from 1 = strongly disagree to 7 = strongly agree.
Total score of the GQ-5 ranges from 5 to 35, with higher scores indicating higher level of gratitude.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Penn State Worry Questionnaire (PSWQ)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The PSWQ is a 16-item self-report instrument designed to measure the construct of worry.
Each item is rated on a 5-point Likert scale that ranges from 1 = not at all typical of me to 5 = very typical of me.
Five items are reversely scored to obtain a total score ranges from 16 to 80.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Liebowitz Social Anxiety Scale (LSAS)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The LSAS assesses fear and avoidance related to social anxiety disorder.
The 24-item scale is divided into two broad domains of situations, with 11 items on social anxiety and 13 items on performance fear.
Each of the 24 items is rated on a 4-point Likert scale of 0 = none to 3 = severe for anxiety items or usually for avoidance items.
The total score of LSAS ranges from 0 to 144.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Obsessive-Compulsive Inventory-Revised (OCI-R)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The OCI-R is an 18-item self-report scale for measuring the severity of obsessive-compulsive symptoms.
Each item is rated on a 5-point Likert scale of 0 = not at all to 4 = extremely.
The OCI-R total score ranges from 0 to 72, with higher scores indicating a greater likelihood of OCD.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Posttraumatic Stress Disorder Checklist for Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (PCL-5)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The PCL-5 is a self-report measure of posttraumatic stress disorder (PTSD) symptom severity, based on its diagnostic criteria in Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5).
Each of the 20 items is rated on a 5-point Likert scale of 0 = not at all to 4 = extremely.
The PCL-5 total score ranges from 0 to 80, with higher scores indicating greater PTSD severity.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Insomnia Severity Index (ISI)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The ISI evaluates the nature, severity, and impact of insomnia.
It consists of 7 items rated on a 5-point Likert scale from 0 = no problem to 4 = very severe problem, with a total score ranging from 0 to 28.
Higher scores on the ISI indicate more severe insomnia.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Short Health Anxiety Inventory (SHAI)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
The SHAI is an 18-item self-report measure that assesses an individual's concern about possibly having health illnesses of different kinds, and the catastrophic thinking about having the illnesses.
Total score of the SHAI ranges from 0 to 54, where higher scores indicate greater health anxiety.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 1-, 2-, 3-, 6-, and 12-month follow-up
|
|
Work and Social Adjustment Scale (WSAS)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The WSAS is a 5-item scale that measures self-report severity of impairment across five domains of functioning.
Each item is rated on a 9-point Likert scale of 0 = not at all to 8 = very severely.
Total score of the WSAS ranges from 0 to 40, where higher scores indicate greater functional impairment.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
|
Rosenberg Self-Esteem Scale (RSES)
기간: Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
The RSE has 10 items that assess self-esteem, each rated on a 4-point Likert scale of 1 = strongly agree to 4 = strongly disagree.
Total score of the RSE ranges from 0 to 30, with lower scores suggesting lower self-esteem.
|
Baseline (week 0), post-intensive (week 5; after completion of core modules), posttreatment (week 14; completion of the intervention), and 3- and 12-month follow-up
|
공동 작업자 및 조사자
여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.
연구 기록 날짜
이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.
연구 주요 날짜
연구 시작 (실제)
2022년 12월 28일
기본 완료 (실제)
2025년 10월 31일
연구 완료 (실제)
2025년 10월 31일
연구 등록 날짜
최초 제출
2026년 5월 8일
QC 기준을 충족하는 최초 제출
2026년 5월 14일
처음 게시됨 (실제)
2026년 5월 20일
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
2026년 5월 20일
QC 기준을 충족하는 마지막 업데이트 제출
2026년 5월 14일
마지막으로 확인됨
2026년 4월 1일
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .